Today: Today, Bronfman E.L. Rothschild L.P. Reached $413,000 position of Amsurg Corp. (AMSG)

Today, Bronfman E.L. Rothschild L.P. Reached $413,000 position  of Amsurg Corp. (AMSG)

Bronfman E.L. Rothschild L.P. boosted its position in shares of Amsurg Corp. (NASDAQ:AMSG) by 14.4% during the third quarter, Holdings Channel reports. The institutional investor owned 6,156 shares of the company’s stock after buying an additional 775 shares during the period. Bronfman E.L. Rothschild L.P.’s holdings in Amsurg Corp. were worth $413,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Vaughan Nelson Investment Management L.P. raised its stake in shares of Amsurg Corp. by 54.8% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 2,949,733 shares of the company’s stock worth $197,780,000 after buying an additional 1,043,915 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in shares of Amsurg Corp. by 2.5% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,588,313 shares of the company’s stock valued at $123,158,000 after buying an additional 38,676 shares during the period. Wells Fargo & Company MN raised its stake in shares of Amsurg Corp. by 20.7% in the third quarter. Wells Fargo & Company MN now owns 1,431,663 shares of the company’s stock valued at $95,993,000 after buying an additional 245,301 shares during the period. Systematic Financial Management LP raised its stake in shares of Amsurg Corp. by 12.5% in the second quarter. Systematic Financial Management LP now owns 1,351,163 shares of the company’s stock valued at $104,769,000 after buying an additional 150,381 shares during the period. Finally, Royal Bank of Canada raised its stake in shares of Amsurg Corp. by 40.2% in the second quarter. Royal Bank of Canada now owns 711,228 shares of the company’s stock valued at $55,147,000 after buying an additional 204,023 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

Amsurg Corp. (NASDAQ:AMSG) opened at 65.875 on Friday. The stock has a 50 day moving average of $64.42 and a 200 day moving average of $70.28. The stock has a market cap of $3.54 billion, a P/E ratio of 20.332 and a beta of 0.67. Amsurg Corp. has a 12-month low of $57.32 and a 12-month high of $86.17.

Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, November 1st. The company reported $1.13 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.13. Amsurg Corp. had a net margin of 6.06% and a return on equity of 8.05%. The company had revenue of $822.20 million for the quarter, compared to the consensus estimate of $770.29 million. During the same quarter in the prior year, the company earned $1.03 EPS. Amsurg Corp.’s quarterly revenue was up 26.5% on a year-over-year basis. On average, equities research analysts anticipate that Amsurg Corp. will post $4.31 earnings per share for the current fiscal year.

Several analysts recently issued reports on the stock. Mizuho lowered shares of Amsurg Corp. from a “buy” rating to a “neutral” rating and cut their target price for the company from $95.00 to $71.00 in a research report on Wednesday, November 9th. Wells Fargo & Co. upgraded shares of Amsurg Corp. from a “market perform” rating to an “outperform” rating in a research report on Wednesday, November 2nd. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Amsurg Corp. from a “sell” rating to a “hold” rating in a research report on Friday, November 4th. Cantor Fitzgerald set a $90.00 target price on shares of Amsurg Corp. and gave the company a “buy” rating in a research report on Wednesday, November 2nd. Finally, KeyCorp restated a “positive” rating and set a $87.00 target price on shares of Amsurg Corp. in a research report on Tuesday, October 4th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $89.45.

Amsurg Corp. Company Profile

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Related posts

Leave a Comment